Literature DB >> 7929526

The difficulty defining "benefit" of new antineoplastic strategies.

M Markman.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7929526     DOI: 10.1007/bf01212809

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  9 in total

Review 1.  High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.

Authors:  D M Eddy
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

Review 2.  Therapeutic alternatives in clinical stage I nonseminomatous disease.

Authors:  M Rørth
Journal:  Semin Oncol       Date:  1992-04       Impact factor: 4.929

3.  A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.

Authors:  R Cellerino; D Tummarello; F Guidi; P Isidori; M Raspugli; B Biscottini; G Fatati
Journal:  J Clin Oncol       Date:  1991-08       Impact factor: 44.544

4.  Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Authors:  P A Ganz; R A Figlin; C M Haskell; N La Soto; J Siau
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

5.  An argument in support of cost-effectiveness analysis in oncology.

Authors:  M Markman
Journal:  J Clin Oncol       Date:  1988-06       Impact factor: 44.544

6.  High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.

Authors:  S F Williams; T Gilewski; R Mick; J D Bitran
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

7.  Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Authors:  S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

8.  High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.

Authors:  M J Kennedy; R A Beveridge; S D Rowley; G B Gordon; M D Abeloff; N E Davidson
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

9.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

Authors:  E Rapp; J L Pater; A Willan; Y Cormier; N Murray; W K Evans; D I Hodson; D A Clark; R Feld; A M Arnold
Journal:  J Clin Oncol       Date:  1988-04       Impact factor: 44.544

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.